Yu Kato

7PUBLICATIONS
95CO-AUTHORS
Molecular targetsGlycoconjugatesInnate immunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 13, 2024
Nonclinical characterization of ICVB-1042 as a selective oncolytic adenovirus for solid tumor treatment.

Yu Kato, Nathaniel Rice, Michael Pokrass

|Dec 03, 2021
A particulate saponin/TLR agonist vaccine adjuvant alters lymph flow and modulates adaptive immunity.

Murillo Silva, Yu Kato, Mariane B Melo

|Oct 22, 2021
Sphingosine 1-phosphate receptor 5 (S1PR5) regulates the peripheral retention of tissue-resident lymphocytes.

Maximilien Evrard, Erica Wynne-Jones, Changwei Peng

|Oct 07, 2021
SARS-CoV-2 infection generates tissue-localized immunological memory in humans.

Maya M L Poon, Ksenia Rybkina, Yu Kato

|Jan 07, 2021
Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection.

Jennifer M Dan, Jose Mateus, Yu Kato

|Aug 26, 2020
Display of Native Antigen on cDC1 That Have Spatial Access to Both T and B Cells Underlies Efficient Humoral Vaccination.

Yu Kato, Thiago M Steiner, Hae-Young Park

Pageof 2